HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Omega Protein, Dr. Axe, No Cow: Health And Wellness Industry News

This article was originally published in The Rose Sheet

Executive Summary

Omega Protein stockholders vote Dec. 19 on proposed acquisition by Cooke; Endexx acquires Holistic Earth Remedies to improve timing for CBD product commercialization; Dr. Axe brands protein; and more health and wellness industry news.

You may also be interested in...



Health, Beauty And Wellness News: Medline Remedy Contamination, GNC Proxy

Omega Protein, Herbalife, MET-Rx: Health And Wellness Industry News

Omega Protein has new home at Canadian aquaculture firm; Herbalife on target with buy-back tender volume, price; and MET-Rx scores Bellinger for promotions.

Vifor Confident About Prospects For Pruritus Dialysis Drug Korsuva

Vifor CEO Stefan Schulze tells Scrip that an expanded deal with Korsuva developer Cara Therapeutics means the US biotech will not have to invest in a commercial organization as the Swiss firm will mobilize its well-established sales force to launch the treatment for dialysis patients with CKD-associated pruritus.

Topics

UsernamePublicRestriction

Register

OM013057

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel